ERG and prostate carcinoma: Combined analysis of the PCAWG and GTEx datasets leads to the hypothesis that a subset of prostate cancers, through genome rearrangement, hijack the promoters of androgen-responsive genes to increase ERG expression, resulting in an androgen-dependent overexpression of ERG.